4.4 Article

Percutaneous Ablation Vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis

Lorenzo Bianchi et al.

Summary: Partial nephrectomy showed higher disease-free survival rates at 5 years compared to local tumor ablation, but overall survival rates were similar. Local tumor ablation had a higher risk of recurrence but lower risk of complications compared to partial nephrectomy.

INTERNATIONAL JOURNAL OF UROLOGY (2022)

Review Biochemistry & Molecular Biology

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets

Nicola Antonio di Meo et al.

Summary: This review article presents the current state-of-the-art in research on ccRCC metabolic pathways and potential therapeutic applications. It highlights the importance of utilizing metabolic profiling for predicting prognosis and selecting treatment strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Urology & Nephrology

Estimated Glomerular Filtration Rate Decline at 1 Year After Minimally Invasive Partial Nephrectomy: A Multimodel Comparison of Predictors

Fabio Crocerossa et al.

Summary: Preoperative eGFR, sex, ischemia technique, and postoperative eGFR percentage loss are the best predictors of eGFR percentage loss at 1 year after minimally invasive PN.

EUROPEAN UROLOGY OPEN SCIENCE (2022)

Article Oncology

Outcomes of robot-assisted partial nephrectomy for completely endophytic renal tumors: A multicenter analysis

Umberto Carbonara et al.

Summary: The study showed that robotic partial nephrectomy for completely endophytic renal tumors can be performed with acceptable outcomes in centers with significant robotic expertise. Achieving the trifecta (negative margin, no postoperative complications, and 90% estimated glomerular filtration rate recovery) was significantly associated with clinical tumor size.
Article Urology & Nephrology

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

Steven C. Campbell et al.

Summary: Significant progress has been made in the evaluation and management of clinically-localized renal masses. These guidelines offer updated, evidence-based recommendations on evaluation and counseling, highlighting the evolving role of renal-mass-biopsy (RMB).

JOURNAL OF UROLOGY (2021)

Article Urology & Nephrology

Robotic-assisted Partial Nephrectomy for Very Small (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort

Umberto Carbonara et al.

Summary: The study demonstrates that robot-assisted partial nephrectomy is a minimally invasive option for patients with very small renal masses, offering advantages such as fewer postoperative complications and minimal impact on renal function.

EUROPEAN UROLOGY FOCUS (2021)

Article Urology & Nephrology

Percutaneous cryoablation for high-complexity renal masses: complications, functional and oncological outcomes

Michele Rizzo et al.

Summary: This study analyzed mid-term outcomes of CA in treating high-complexity cT1 renal masses, showing that CA provides good preservation of renal function for patients, although there is a higher recurrence rate compared to surgically treated patients.

MINERVA UROLOGY AND NEPHROLOGY (2021)

Review Urology & Nephrology

Comparison of outcomes between laparoscopic and robot-assisted partial nephrectomy for complex renal tumors: RENAL score ≥7 or maximum tumor size >4 cm

Pengxiu Lin et al.

Summary: For complex renal tumors, RAPN is more favorable than LPN in terms of lower rate of conversion to radical surgery, shorter ischemia time, shorter length of stay, less eGFR decline, and lower rate of CKD upstaging.

MINERVA UROLOGY AND NEPHROLOGY (2021)

Article Medicine, Research & Experimental

Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell Carcinoma

Toshihiro Uemura et al.

Summary: In patients with cT1a RCC, oncological outcomes and renal function preservation appear to be similar following treatment with RAPN and PCA, according to the study findings.

IN VIVO (2021)

Review Radiology, Nuclear Medicine & Medical Imaging

Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis

Johannes Uhlig et al.

EUROPEAN RADIOLOGY (2019)

Article Urology & Nephrology

Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses

Jack R. Andrews et al.

EUROPEAN UROLOGY (2019)

Editorial Material Urology & Nephrology

Guidelines for Reporting of Statistics for Clinical Research in Urology

Melissa Assel et al.

EUROPEAN UROLOGY (2019)

Article Urology & Nephrology

Available ablation energies to treat cT1 renal cell cancer: emerging technologies

P. J. Zondervan et al.

WORLD JOURNAL OF UROLOGY (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients

J. Ricardo Rivero et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)

Review Oncology

The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses

Maciej Salagierski et al.

EUROPEAN UROLOGY ONCOLOGY (2018)

Review Urology & Nephrology

Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis

Hiten D. Patel et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Urology & Nephrology

EAU Guidelines on Renal Cell Carcinoma: 2014 Update

Borje Ljungberg et al.

EUROPEAN UROLOGY (2015)